| P2093 | author name string | Schwarz EM | |
| | Wooley PH | |
| P2860 | cites work | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | The NF-kappa B and I kappa B proteins: new discoveries and insights | Q24313579 |
| | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| | A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 |
| | Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 |
| | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 |
| | Bone loss. Factors that regulate osteoclast differentiation: an update | Q24805142 |
| | In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis | Q28216662 |
| | RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis | Q28293009 |
| | Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases | Q29547555 |
| | Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 |
| | Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism | Q33726838 |
| | Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes | Q33966333 |
| | Osteoclasts, integrins, and osteoporosis. | Q34071057 |
| | Requirement for NF-kappaB in osteoclast and B-cell development | Q35199657 |
| | Cytokines in autoimmunity | Q35605060 |
| | Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. | Q35754620 |
| | Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated disease | Q35882174 |
| | RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 |
| | TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand | Q37413745 |
| | Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis | Q40410066 |
| | Efficacy of etanercept for wear debris-induced osteolysis | Q40825159 |
| | An interleukin 1 like factor stimulates bone resorption in vitro. | Q40832279 |
| | Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis | Q40862558 |
| | Estrogen, cytokines, and the control of osteoclast formation and bone resorption in vitro and in vivo | Q40891123 |
| | Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha | Q40923161 |
| | Revision total hip arthroplasty with use of so-called second-generation cementing techniques for aseptic loosening of the femoral component. A fifteen-year-average follow-up study. | Q40977369 |
| | Nitric oxide release by macrophages in response to particulate wear debris | Q41026291 |
| | The effects of cobalt chromium upon macrophages | Q41026310 |
| | Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids | Q41283123 |
| | Response of three murine macrophage populations to particulate debris: bone resorption in organ cultures | Q41444921 |
| | Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways | Q42494588 |
| | Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles | Q42523628 |
| | Titanium, chromium and cobalt ions modulate the release of bone-associated cytokines by human monocytes/macrophages in vitro | Q42551825 |
| | Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse | Q42708312 |
| | IL-1Ra and vIL-10 gene transfer using retroviral vectors ameliorates particle-associated inflammation in the murine air pouch model | Q44081938 |
| | Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model | Q45730626 |
| | Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis. | Q45881989 |
| | Effects of cytokine gene therapy on particulate-induced inflammation in the murine air pouch | Q45883159 |
| | Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis | Q45884566 |
| | In vitro activation of human fibroblasts by retrieved titanium alloy wear debris. | Q46035407 |
| | Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement | Q46089370 |
| | Effects of polyethylene particles on tissue surrounding knee arthroplasties in rabbits | Q47996816 |
| | Dexamethasone attenuates NF-kappa B DNA binding activity without inducing I kappa B levels in rat brain in vivo | Q48747925 |
| | Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. | Q52192178 |
| | Osteoclastic differentiation by mononuclear phagocytes containing biomaterial particles. | Q54143530 |
| | Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. | Q54784059 |
| | Bone-resorbing cytokines in serum of patients with aseptic loosening of hip prostheses | Q57014140 |
| | Cellular mediators secreted by interfacial membranes obtained at revision total hip arthroplasty | Q57528259 |
| | Expression of functional RANK on mature rat and human osteoclasts | Q57533748 |
| | Biomaterial Particle Phagocytosis by Bone-Resorbing Osteoclasts | Q61703907 |
| | Prosthesis-associated pseudomembrane-induced bone resorption | Q68714875 |
| | Analysis of cell types and mediator production from tissues around loosening joint implants | Q71017828 |
| | Assessment of the role of GM-CSF in the cellular transformation and the development of erosive lesions around orthopaedic implants | Q71064075 |
| | Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4 | Q71098370 |
| | Polymethylmethacrylate‐stimulated macrophages increase rat osteoclast precursor recruitment through their effect on osteoblasts in vitro | Q71848757 |
| | Immunocytochemical localization of inflammatory cytokines and vascular adhesion receptors in radicular cysts | Q72085172 |
| | The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice | Q72547422 |
| | Effect of polyethylene wear on osteolysis in cementless primary total hip arthroplasty: minimal 5-year follow-up study | Q73061588 |
| | Cytokine response of human macrophage-like cells after contact with polyethylene and pure titanium particles | Q73121193 |
| | Macrophage-colony stimulating factor (M-CSF) is increased in the synovial-like membrane of the periprosthetic tissues in the aseptic loosening of total hip replacement (THR) | Q73417840 |
| | Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis | Q73472299 |
| | Development and characteristics of a synovial-like interface membrane around cemented tibial hemiarthroplasties in a novel rat model of aseptic prosthesis loosening | Q73792186 |
| | Production of platelet-derived growth factor in aseptic loosening of total hip replacement | Q74565249 |
| | Cubital tunnel syndrome associated with medial elbow Ganglia and osteoarthritis of the elbow | Q74606610 |
| | Interleukin-11 (IL-11) in aseptic loosening of total hip replacement (THR) | Q77531359 |
| P433 | issue | 4 | |
| P304 | page(s) | 402-407 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Aseptic loosening | |
| P478 | volume | 11 | |